Melanotan II raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-09-22. Anything still debated is marked as such rather than presented as settled.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Belongs to the melanocortin agonist family |
| Key substitutions | Nle4 and D-Phe7 | Improve resistance to enzymatic degradation |
| Molecular formula | C50H69N15O9 | Approximately 1024 g/mol |
| Regulatory status | Not approved as a medicine | Distributed as a research chemical |
| Common synonyms | Melanotan II, MT-II, MT-2 | Spelling varies across sources |
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
I.E.M. (album) Inborn error of metabolism In-ear monitors, devices used by musicians, audio engineers and audiophiles to listen to music Incredible Expanding Mindfuck (Music) Information Engineering Methodology Institute of Electronic Music and Acoustics (Institut für Elektronische Musik und Akustik), part of the University of Music and Performing Arts, Graz Institute of Engineering and Management Integrated Enterprise Modeling Institute of Engineering in Medicine, part of the University of California, San Diego Institute for Experimental Mathematics, a central scientific facility of the University of Duisburg-Essen Intel Extreme Masters, a series of international esports tournaments International emergency medicine Internet Explorer Mobile Ion evaporation model, a model explaining electrospray ionization in mass spectrometry Iowa Electronic Markets Internal Energy Market, of the European Union
=== Physical and atomic === Darmstadtium is expected to be a solid under normal conditions and to crystallize in the body-centered cubic structure, unlike its lighter congeners which crystallize in the face-centered cubic structure, because it is expected to have different electron charge densities from them. It should be a very heavy metal with a density of around 26–27 g/cm3. In comparison, the densest known element that has had its density measured, osmium, has a density of only 22.61 g/cm3. The outer electron configuration of darmstadtium is calculated to be 6d8 7s2, which obeys the Aufbau principle and does not follow platinum's outer electron configuration of 5d9 6s1. This is due to the relativistic stabilization of the 7s2 electron pair over the whole seventh period, so that none of the elements from 104 to 112 are expected to have electron configurations violating the Aufbau principle. The atomic radius of darmstadtium is expected to be around 132 pm.
After oral administration, zopiclone is rapidly absorbed, with a bioavailability around 75–80%. Time to peak plasma concentration is 1–2 hours. A high-fat meal preceding zopiclone administration does not change absorption (as measured by AUC), but reduces peak plasma levels and delays its occurrence, thus may delay the onset of therapeutic effects. The plasma protein-binding of zopiclone has been reported to be weak, between 45 and 80% (mean 52–59%). It is rapidly and widely distributed to body tissues, including the brain, and is excreted in urine, saliva, and breast milk. Zopiclone is partly extensively metabolized in the liver to form an active N-demethylated derivative (N-desmethylzopiclone) and an inactive zopiclone-N-oxide. Hepatic enzymes playing the most significant role in zopiclone metabolism are CYP3A4 and CYP2E1. In addition, about 50% of the administered dose is decarboxylated and excreted via the lungs. In urine, the N-demethyl and N-oxide metabolites account for 30% of the initial dose. Between 7 and 10% of zopiclone is recovered from the urine, indicating extensive metabolism of the drug before excretion. The terminal elimination half-life of zopiclone ranges from 3.5 to 6.5 hours (5 hours on average). The pharmacokinetics of zopiclone in humans are stereoselective.
Sources: en.wikipedia.org
parietina has more limited genetic exchange between nearby populations than previously thought, possibly due to habitat specialization. Molecular investigations into the mating-type (MAT) loci have further revealed the reproductive strategies within Xanthoria. While X. parietina is homothallic—possessing only a MAT1-2 gene (although truncated)—species such as X. polycarpa are heterothallic, with distinct MAT idiomorphs (different mating-type genetic regions). These differences in mating system structure can significantly affect population genetics, influencing levels of genetic diversity, gene flow, and ultimately speciation processes within the genus.
== Safety and tolerability == Across clinical studies, icotrokinra has demonstrated a favorable safety profile. In phase III trials for plaque psoriasis, the most common adverse events were upper respiratory tract infections and headache. Pooled safety data from multiple studies showed similar rates of adverse events between icotrokinra and comparator groups.
Vanchiglia is bordered by Corso San Maurizio, Corso Regio Parco and the River Po, crossed also by the River Dora Riparia and by two big avenues, Corso Regina Margherita and Corso Tortona. Borgo Vanchiglia is the historical district: a little triangle next to downtown, situated between Corso San Maurizio, Corso Regina Margherita and the River Po. The district is quite popular nowadays because being quite closer to the heart of Turin nightlife Piazza Vittorio Veneto, many bars and restaurants opened recently in this area. However, Vanchiglia also includes the area called Vanchiglietta, north of Borgo Vanchiglia. Notable church in Borgo Vanchiglia is the French neo-Gothic Chiesa di Santa Giulia situated into Piazza Santa Giulia.
Sources: en.wikipedia.org
=== Organic compound peptide-based batteries === StoreDot reported in 2014 to have developed organic-compound peptide-based smartphone batteries capable of being fully charged within 30 seconds. The company said its 30-second-charging organic-compound-based battery would be commercially available for smartphones by 2016. The company announced its 5-minutes-to-full-charge organic batteries will be available for 300-mile-range electric vehicles and aerial drones by 2020. The company acknowledged in 2015 that its claims regarding its organic batteries have not been scientifically peer-reviewed.
Morpholinos can interfere with pre-mRNA processing steps either by preventing splice-directing small nuclear ribonucleoproteins (snRNP) complexes from binding to their targets at the borders of introns on a strand of pre-mRNA, or by blocking the nucleophilic adenine base and preventing it from forming the splice lariat structure, or by interfering with the binding of splice regulatory proteins such as splice silencers and splice enhancers. Preventing the binding of snRNP U1 (at the donor site) or U2/U5 (at the polypyrimidine moiety and acceptor site) can cause modified splicing, commonly excluding exons from the mature mRNA. Targeting some splice targets results in intron inclusions, while activation of cryptic splice sites can lead to partial inclusions or exclusions. Targets of U11/U12 snRNPs can also be blocked. Splice modification can be conveniently assayed by reverse-transcriptase polymerase chain reaction (RT-PCR) and is seen as a band shift after gel electrophoresis of RT-PCR products.
Aurora is one of the most ancient districts which developed out of the medieval city walls, north of the historical city centre. It stretches from downtown northern boundaries in Corso Regina Margherita (an extended and important thoroughfare of Turin) up to Corso Vigevano and Corso Novara in the North Side (namely the old excise boundary until the early 20th century); the western boundary is Corso Principe Oddone (now part of the Spina Centrale boulevard) and the eastern border is the River Dora. The district was named Aurora after the so-called Cascina Aurora, an old farmstead lying north of the River Dora, right at the intersection between Corso Giulio Cesare and Corso Emilia. The farmstead has long been demolished and the area has been converted to office buildings, hosting the Turinese textile company Gruppo Finanziario Tessile (GFT) headquarters until the early 21st century. The historical hub of the district is Borgo Dora (The 'Dora Borough'), a small neighbourhood next to Porta Palazzo and enclosed by Corso Regina Margherita, Via Cigna, the River Dora and Corso Giulio Cesare. Once known as Borgo del Pallone ('Ball Borough') or Balon in Piedmontese dialect (locally [baˈlun]), this neighbourhood is known for its mercatino del Balon or simply Balon, the Turinese flea market that opens every Saturday in its tiny and twisted streets.
Sources: en.wikipedia.org
It is a synthetic cyclic peptide designed as an analog of alpha-melanocyte-stimulating hormone. It acts on melanocortin receptors and is best known from research into pigmentation. It is not an approved pharmaceutical product.
No regulatory agency has approved it for any indication. It is encountered as a research chemical sold outside pharmaceutical supply chains. Products marketed this way are not subject to the manufacturing and labeling requirements that apply to approved drugs.
Reports describe increased skin pigmentation as well as side effects such as nausea, flushing, and changes to existing moles. Much of the evidence comes from small studies and case reports rather than large trials. The long-term safety profile is therefore uncertain.
Regulatory treatment varies by country. In the United States, the European Union and Australia it is an unapproved drug and its sale is restricted, while some other jurisdictions list it as prescription-only or controlled. The applicable rules depend on the country of import.